MedTrace Logo

German Cardiac Arrest Registry

NCT05142124 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2026-02-12

No results posted yet for this study

Summary

In Germany, 70.000 to 100.000 patients suffer from out-of-hospital cardiac arrest (OHCA) every year. More than half of these are due to cardiac causes. Despite the medical progress over the last decades, rates of survival with good neurological outcome remain low. For many below-mentioned issues, no adequate evidence from randomized trials is available. Therefore, a systematic and standardized recording of the pre-clinical, clinical and post-clinical treatment course and of the clinical outcomes of OHCA patients is essential to improve patient care. Aim of the German Cardiac Arrest Registry (G-CAR) is to achieve a better understanding of the disease entity, leading to an optimized treatment of OHCA patients. The recorded data include information on demographic and psychosocial aspects, course of the disease, clinical, laboratory and other examinations as well as treatment modalities in patients with OHCA due to a cardiac cause.

Conditions

  • Out-of-hospital Cardiac Arrest

Sponsors & Collaborators

  • Helios Health Institute GmbH

    collaborator OTHER

  • Heart Center Leipzig - University Hospital

    collaborator OTHER

  • IHF GmbH - Institut für Herzinfarktforschung

    collaborator OTHER

  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER

  • St. Antonius Hospital

    collaborator OTHER

  • Klinikum Ludwigshafen

    collaborator OTHER

  • University of Magdeburg

    collaborator OTHER

  • Charite University, Berlin, Germany

    collaborator OTHER

  • University Hospital of Cologne

    collaborator OTHER

  • Leipzig Heart Science gGmbH

    lead OTHER

Principal Investigators

  • Janine Pöss, Dr. · Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-21
Primary Completion
2026-12-31
Completion
2027-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05142124 on ClinicalTrials.gov